(Hypertension. 1995;26:1065-1069.)
© 1995 American Heart Association, Inc.
Articles |
Effects of Dehydroepiandrosterone Sulfate on Cellular Calcium Responsiveness and Vascular Contractility
From the University of Palermo (Italy) (M.B.); Division of Endocrinology and Hypertension, Wayne State University, Detroit, Mich (M.B., L.M.R.); and Department of Physiology, University of Alberta, Edmonton, Alberta, Canada (J.S., P.K.T.P.).
Abstract Dehydroepiandrosterone sulfate (DHEAS) is an endogenous steroid having a wide variety of biological effects, but its physiological role remains undefined. Since an age-related decline of DHEAS corresponds to the progressive onset of atherosclerosis, cardiovascular diseases, and overall mortality, we investigated a possible protective role of DHEAS in vascular disease by studying the effects of this hormone (10-7 to 10-5 mol/L) on cytosolic free calcium and contractility in different in vitro vascular tissue preparations. DHEAS produced a significant, dose-dependent relaxation of isolated helical strips of rat tail artery precontracted with KCl (60 mmol/L) (89.7±18.7%, P<.01), arginine vasopressin (3 nmol/L) (27.3±7.1%, P<.01), and norepinephrine (0.1 µmol/L) (49.2±18.2%, P<.01). In isolated vascular smooth muscle cells DHEAS reversibly inhibited KCl (30 mmol/L)–induced elevations of cytosolic free calcium to 69.8±8.4% and 43.8±7.4% of the control response at 5x10-7 and 5x10-6 mol/L, respectively (P<.05 at both doses). These results provide evidence of a direct vascular action of DHEAS, in doses reflecting circulating levels in vivo, and suggest the possibility that these effects are mediated by modulation of intracellular calcium metabolism. We hypothesize that physiologically, DHEAS may serve to buffer vascular responsiveness to a wide variety of depolarizing and constrictor hormonal stimuli.
Key Words: calcium • muscle, smooth, vascular • hormones • dehydroepiandrosterone sulfate (prasterone)
This article has been cited by other articles:
 |
|
 |
|
  D. Liu, M. Iruthayanathan, L. L. Homan, Y. Wang, L. Yang, Y. Wang, and J. S. Dillon Dehydroepiandrosterone Stimulates Endothelial Proliferation and Angiogenesis through Extracellular Signal-Regulated Kinase 1/2-Mediated Mechanisms Endocrinology, March 1, 2008; 149(3): 889 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Liu, H. Si, K. A. Reynolds, W. Zhen, Z. Jia, and J. S. Dillon Dehydroepiandrosterone Protects Vascular Endothelial Cells against Apoptosis through a G{alpha}i Protein-Dependent Activation of Phosphatidylinositol 3-Kinase/Akt and Regulation of Antiapoptotic Bcl-2 Expression Endocrinology, July 1, 2007; 148(7): 3068 - 3076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Molinari, A. Battaglia, E. Grossini, D. A. S. G. Mary, C. Vassanelli, and G. Vacca The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs J. Physiol., May 15, 2004; 557(1): 307 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Molinari, A Battaglia, E Grossini, D A S G Mary, C Vassanelli, and G Vacca The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs J. Physiol., June 15, 2003; 549(3): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barbagallo, L. J. Dominguez, G. Licata, J. Shan, L. Bing, E. Karpinski, P. K. T. Pang, and L. M. Resnick Vascular Effects of Progesterone : Role of Cellular Calcium Regulation Hypertension, January 1, 2001; 37(1): 142 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.P. Bernini, M. Sgro’, A. Moretti, G.F. Argenio, C.O. Barlascini, R. Cristofani, and A. Salvetti Endogenous Androgens and Carotid Intimal-Medial Thickness in Women J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2008 - 2012. [Abstract] [Full Text]
|
|